Biomarkers Across Neurodegenerative Diseases (BAND) – Full Application
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit:
Memorial Deadline: Inquire with RGCS
External Deadline: Saturday 1st, December 2018
Description
The Alzheimer’s Association (ALZ), Alzheimer’s Research UK (ARUK), The Michael J. Fox Foundation for Parkinson’s Research (MJFF), and the Weston Brain Institute (Weston) announce a global Request for Applications (RFA). The main objective of BAND is to stimulate analyses across Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases to increase understanding of pathogenesis similarities and differences. The intent of this RFA is to analyze across existing data; biological samples are not available for use under this RFA. Funding from this program may support but is not limited to projects that aim to develop and/or advance innovative data models, biomarker discovery, assay standardization, genetic profiling, harmonize existing data set phenotypes, analyze cross-disease or longitudinal analyses of existing data, inclusion of other neurodegenerative diseases related to PD and AD, or imaging development.
For additional details on the program, please visit the Weston brain Institute’s website.
Important Deadlines
| July 15, 2018 | Website access opens to application materials |
| August 20, 2018 | Informational conference call* |
| Sept 10, 2018 | Letters of intent due |
| October 22, 2018 | Full applications invited |
| December 1, 2018 | Full applications due |
| March 2019 | Anticipated award announcements |
| April 2019 | Anticipated funding |